Clinical Trial Update: Magnesium and Riboflavin Treatment for Post-Concussion Headache [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating magnesium and riboflavin for post-concussion headache, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Concussion
• Post-concussion Syndrome

Drugs mentioned

• Magnesium (magnesium)
• Riboflavin (riboflavin)

Snippet

Sponsor: University of Virginia | Conditions: Concussion, Intermediate | Phase 2 | Status: RECRUITING